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             Radiotherapy is the clinical application of the ionizing radiation to treat cancer. 
Ionizing radiation causes multiple modes of damage to the DNA damage such as SSBs, DSBs 
and modified bases such as thymine glycol. These lesions can exist as clusters in one or two 
helical turns of DNA.  DNA double-strand breaks (DSBs) are extremely toxic to cells because 
they can lead to genomic rearrangements and even cell death. If base lesions accompany these 
DSBs, there will be a substantial hindrance for repair.   
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NHEJ is the primary DSB repair pathway in mammalian cells. HRR repairs single strand breaks 
(SSBs) or Double strand breaks (DSBs), during late S phase and G2 phase of the cell cycle, by 
using an undamaged copy of the DNA sequence, and is therefore largely error-free. The NHEJ 
pathway repairs DSBs without the requirement for sequence homology and can be error-free or 
error-prone, and is most active during G1 phase. 
Thymine glycol (Tg) is the most common oxidation product of thymine. It is produced 
endogenously as a consequence of aerobic metabolism or via exogenous factors such as ionizing 
radiation (IR); it is one of the predominant types of base modifications produced by ionizing 
radiation. Due to clustering of radiation-induced damages, many DSBs are accompanied by 
damaged bases such as Tg at or near the DSB ends that may interfere with subsequent gap filling 
and ligation. The base excision repair pathway plays a major role in removal of thymine glycol 
from the damaged DNA strand. During NHEJ, after synapsis by Ku and DNAPKcs and 
processing of the DNA ends, XRCC4/Ligase IV complex ligates the DNA. This ligase activity is 
promoted by the interaction of XLF/XRCC4 filament with Ligase IV.  
   Linearized plasmids with Tg at the 5th -Tg5 positions from the broken end were subjected to a 
repair assay using XRCC4-like factor (XLF)-deficient cell extracts, with or without the addition 
of XLF and Endonuclease III and/or ddTTP and Klenow fragments. End joining of Tg5 was 
compared to plasmid with Tg at third position-Tg3 in extracts. In addition, the ability of purified 
NHEJ proteins Ku, DNAPKcs and XRCC4/Ligase IV, to repair the Tg1 (Tg at the end), Tg2 (Tg 
at the second position), Tg3 and Tg5 in the presence and absence of XLF was assessed. 
 The data indicated that the cell extract could ligate the Tg5 plasmids only in the presence of 
XLF. End joining of the Tg5 was less in comparison to Tg3 with base excision repair being more 
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active in Tg5 competing with the joining. Plasmids with Tg were treated with Endonuclease III 
and ddTTP to test whether the end joining occurred before or after Tg removal.  
     Endonuclease III and ddTTP treatment showed reduced intensity of the joined fragment 
suggesting that end joining occurred without removal of Tg in some cases. The extracts were not 
able to fill in the processed end by the BER though it has a 3′-OH which was filled in by the 
treatment with Klenow enzymes derived from E.coli DNA Polymerase I, following removal of 
extract proteins by proteolysis. When purified proteins were used to treat the plasmids, it is 
observed that there was increased efficiency of repair with increased distance of the Tg from the 
end may be due to less distortion of the ends as Tg is away from the end.  While Tg1 and Tg2 
required XLF presence for the repair, Tg3 and Tg5 could show a small amount of repair in its 
absence.  XLF enhanced the repair of Tg3 and Tg5.  While the repair by extract showed no repair 
in the same substrates without XLF, there was repair by purified proteins without XLF, 
suggesting there is some competition with the XRCC4/Ligase for the DSB by other proteins and 
XLF is required to overcome this. 
In conclusion, cell extract was able to ligate the plasmid with Tg located at fifth position from 
the DSB but with lower efficiency compared to Tg3 plasmids. The base excision repair pathway 
is more functional if the modified base is far from the DSB. End joining by the purified proteins 
was proportional to the thymine glycol position from the DSB end. XLF was mandatory for 
repair of Tg1 and Tg2 by the purified proteins, and not for Tg3 and Tg5. 
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                                                                 INTRODUCTION 
 
 
1.1 Radiotherapy: 
Clinical application of ionizing radiation, radiotherapy, is one crucial treatment option in cancer 
therapy apart from surgery and systemic therapy. More than 60% of the cancer patients receive 
radiation as a treatment modality today. Approximately, 45% of new cancer cases will receive 
radiotherapy (RT) and this proportion is increasing 
[1]
. Moreover, RT is responsible for 40% of 
cancer cure providing an excellent cost-effectiveness ratio 
[2]
. Radiotherapy can be used in 
various treatment settings as a definitive strategy or in multimodal settings as in adjuvant or 
neoadjuvant settings, with or without concomitant chemotherapy.  Radiotherapy can rescue the 
surgical amputations, yielding better cosmesis and can also be used in palliative settings 
[1, 3]
. 
Radiotherapy can not only significantly prolong patient survival but can also improve the local 
and metastatic control rates of tumors.  
The main subcellular target for the radiotherapy is DNA.  The effect of radiotherapy can  be a 
lethal damage, which is unrepairable and causes cell death irrevocably   or   sub lethal resulting 
in  sub lesions  which can be repaired by the repair response pathways in the cell under normal 
circumstances unless additional damage is added or interference with the pathways  exist.       
Basically, three modalities of cell death occur, Mitotic 
[4]
, permanent arrest in G1
 [5]
 or Apoptosis
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[6]
. Though the radiotherapy is directed to kill cancer cells, there is a probability of damage to the 
normal cells surrounding the tumor; radiotherapy by itself is pre-carcinogenic rendering normal 
cells to cancer cells and induces secondary cancers in primary tissue. Of all the lesions created in 
the DNA by radiotherapy, DSB are notorious for causing cell death 
[7-9]
. 
Whenever there is cell damage with the radiation, as with the other modes of damage there is 
activation of robust repair pathways depending on the damage and the phase of the cell cycle. 
This activation of the repair pathways renders the tumor more radio resistant. Studies show that 
cells that are defective in the repair proteins are radiosensitive. Based on these data, attempts are 
being made to disrupt the various repair pathways using specific inhibitors and subsequent 
exposure to radiotherapy. 
1.2 DNA structure and Radiation induced DNA damage: 
Deoxyribonucleic acid (DNA) is a molecule that encodes the genetic instructions for the 
development and functioning of all known living organisms and many viruses. It exists as 
“double helix” formed by two biopolymer strands running antiparallel to each other. DNA is 
composed of multiple nucleotides of guanine (G), adenine (A), thymine (T), or cytosine (C) — 
with a monosaccharide sugar called deoxyribose and a phosphate group.  The deoxyribose sugars 
are joined at both the 3′ -hydroxyl and 5′ -hydroxyl groups to phosphate groups in ester links, 
also known as "phosphodiester" bonds with an alternating sugar-phosphate sequence of the DNA 
back bone. Two polymers of the nucleotides run antiparallel to each other and held together by 
the hydrogen bonds. DNA sequences are highly conserved in evolution and its integrity is 
essential for the normal functioning of the cell. DNA is continuously under both physiological 
and pathological stress, expressed as DNA damage. Programmed DNA breaks are formed during 
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homologous recombination that occurs during meiosis 
[10, 11]
, during replication and during 
regulated genome rearrangements in lymphocytes [V (D) J] and germ cells 
[12, 13, 14]
. Mutagens 
such as oxidizing agents, alkylating agents, X-rays and also high-energy electromagnetic 
radiation such as ultraviolet light can produce DNA breaks. UV radiation can potentially cause 
DNA damage such as thymidine dimers 
[15]
 and free radicals generated from hydrogen peroxide 
produce various forms of damage, including base modifications, especially of guanosine, and 
double-strand breaks 
[16]
.  On an average about 150,000 bases undergo oxidative damage per day 
in a typical human cell 
[17]
.    Ionizing radiation can produce lethality in cells by inducing DNA 
damage including single and double strand breaks, oxidation of purine and pyrimidine bases and 
crosslinks with proteins.  Of all the oxidative lesions, double-strand breaks are the most 
dangerous and are difficult to repair. Attempted repair produces insertions and deletions, point 
mutations and chromosomal translocations
 [18].  
Two main pathways take part in the DNA double-
strand breaks (DSBs) repair: homologous recombination and nonhomologous recombination.  
Either of the pathways have the propensity to be error prone.  Loss of Heterozygosity (LOH) - 
loss of the only present allele of tumor suppressor genes can occur in HR and NHEJ is the 
primary cause of translocations 
[19, 20] 
and dysfunctional telomeres fusion
 [21]
.  These mutations 
ultimately result in cancer. 
1.3 Double strand breaks: 
DNA-double strand breaks are considered to be the most deleterious lesions caused by ionizing 
radiation in case of a defective repair
 [22,23]
. DSB can also be produced by radiomimetic drugs, 
inducing free radical damage of deoxyribose and topoisomerase-II inhibitors, by inhibiting the 
joining of breaks created by topoisomerase II.  DSB can also be produced from DNA 
SSBs(during replication),  by specific nucleases during V(D)J and class switch recombination in 
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vertebrate lymphocytes, meiotic recombination in germ cells and retroviral integration 
[24]
. DSBs 
naturally occurring at chromosome ends expose telomeres resulting in critical shortening, leading 
to human cell aging 
[25]
.   DSBs can be as simple as the occurrence of two single-strand breaks 
(SSBs) within approximately 6-10 base pairs caused by a single radiation track or complex in 
association with abasic sites (apurinic or apyrimidinic) or damaged bases( oxidized purines and 
pyrimidines) at the clustered damage sites
[26,27]
 . Both simple and complex DSB induced by 
ionizing radiation can have 3′ blocking ends, e.g. 3′-phosphate or 3′-phosphoglycolate moieties 
[29] or possess single-stranded overhangs of variable length.  Repair of these complex lesions is 
more difficult than the isolated lesions and sometimes they are irreparable, enhancing the 
chromosomal aberrations and carcinogenesis. 
1.4 Clustered DNA damage: 
Clusters of the DNA lesions are the signature mark of a single track of radiation consisting of 
two or more individual lesions within one or two helical turns of the DNA 
[28-32]
.  As shown in 
Fig 1.1 the lesions can be  a complex DSB with damaged base and/or abasic (AP) sites directly 
adjacent to the DSB ends
[33-35]
 or non-DSB clusters with the combination of two or more 
oxidized base, strand break or other DNA lesion that do not form a DSB.   Closely associated 
base lesions, such as oxidized guanine [8-oxo-7, 8- dihydroguanine (8-oxoG)] and thymine 
glycol [5, 6- dihydroxy-5, 6-dihydrothymine or thymine glycol (Tg)] with other types of base 
lesions or apurinic/apyrimidinic (AP) sites exist in clusters 
[36-38]
. In contrast, endogenous 
processes produce individual lesions which are more homogenously distributed 
[39-41]
. The 
damage caused by the radiation can be a direct deposition of energy or indirectly via formation 
of reactive chemical species in the surrounding of DNA 
[42, 43]
. Radiolysis of water in the vicinity 
of the DNA is primarily attributed to the production of hydroxyl radicals (OH
-
). All four types of 
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bases are equally sensitive to the attack by the OH
-
 , as the energy deposition is proportional to 
mass 
[42]
. The formation of these clusters depends on the quality of the radiation and the 
presence/absence of oxygen. The number of individual DNA lesions per unit of absorbed dose is 
about the same for low- and high-Linear Energy Transfer radiations 
[44]
. The distribution of these 
lesions is within a smaller number of sites (segments of DNA), implying a higher level of cluster 
complexity, i.e., the average number of lesions per cluster tends to increase with increasing LET. 
Under both aerobic and anaerobic conditions the complexity of the clusters increases with the 
dose of LET as predicted by the measure of SSB to DSB ratio. There will be a decrease in the 
cluster complexity as the oxygen levels go down, thus hypoxic condition contributing to radio-
resistance in tumor therapy 
[45]
.  The repair of the non-DSB cluster lesions is attempted by Base 
Excision Repair pathway proteins   APE1 or PARP1,as evidenced from recent studies using 
primary human fibroblasts 
[46]
 or cell extracts 
[47]
. The type of lesion and the inter-lesion distance 
and the orientation of nearby lesions (e.g., bi-stranded or tandem lesions) are the rate limitation 
to the process. There will be a reduction or inhibition of the processing enzymes such as the 
glycosylases and nucleases. This slow processing of the lesions leads to the persistence of these 
lesions until they hit a replication fork leading to the formation of chromosome breaks, mutations 
and misrepair 
[48, 49]
. There will be formation of inadvertent DSB from these clustered lesions 
during the repair or replication 
[50]
. Human AP-endonuclease-1 (hAPE1) is also capable of 
producing a DSB by cleaving the two opposite stranded AP sites. DSB can also result from the 
formation of nick in the intact strand, during processing of the apyrimidinic site on the opposite 
strand. There is a hierarchy of the repair of the lesions in case of three or more complex lesions 
in order to avoid the formation of DSB 
[53]
. There is a severe impairment of the excision of a base 
lesion such as 8-oxo-guanine, opposing an AP site or strand break until the AP site/strand break 
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is repaired, though it occurs slowly due to the opposed damaged base 
[52]
. DSBs clustered DNA 
lesions either resulting from the direct action of the radiation or as a result of processing of non-
DSB clusters are repaired by the NHEJ pathways to produce less complex clusters 
[53]
. When the 
DSB is due to replication fork hitting the clustered SSB lesion, the repair is by a homologous 
recombination 
[54-56]
. 
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Fig 1.1: Schematic representation of Clustered damage in DNA by the ionizing radiation 
                                                                                                            Alexandros et al., 2013   
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1.5 Thymine Glycol: 
Thymine glycol is the most common damaged base formed due to oxidation of thymine or 
deamination and oxidation 5-methyl-cytosine by ionizing radiation 
[57]
, cancer therapy or 
endogenous aerobic metabolism 
[58]
. Radiation generates oxidants that can react with thymine 
leading to the formation of thymine glycol, thymine peroxide, thymine hydro peroxide, and other 
oxidized forms of the base. Further reaction of these products yields urea.  Approximately 10%-
20% of the radiation or radiotherapy induced damage results in thymine base oxidation and 
fragmentation 
[59]
. Thymine glycol has four diastereomers of, i.e. (5R, 6S), (5R, 6R), (5S, 6R) 
and (5S, 6S), but exists as either the 5R cis–trans pair [(5R, 6S) and (5R, 6R)] or the 5S cis–trans 
pair [(5S, 6R) and (5S, 6S)] in solution, due to epimerization at the C6 position 
[60]
. Oxidation of  
thymidine or thymidine in the oligonucleotides preferentially yields (5R, 6S)-thymine glycol 
[61, 
62]
. Depending on the base that is oxidized, the counter base can be either A or G. Thymine 
glycol induces both structural and functional perturbations of the DNA. Free radical addition to 
the C (5)C (6) double bond of pyrimidines leads to a class of nonplanar ring-saturated lesions, 
unable to form hydrogen bonds with the opposite base taking conformations which are unstable 
in the solution 
[62,63]
. Due to the interaction of the Tg with the polymerases, structural changes 
can be induced at both initiation and termination points resulting in the alteration of the relative 
amounts of termination bands of DNA synthesis 
[64]
. Thymine glycol is a weak mutagen and can 
primarily block replication 
[65-76]
. Studies using a template containing thymine glycol for primer 
extension studies with several DNA polymerases have shown that the extension occurs up to the 
site of Tg with adenine insertion and not beyond
 [66-68]
. Thymine glycol is capable of blocking 
both the repair and replicative polymerases in vitro and can be lethal in vivo
 [71, 72]
.  However 
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there are several contexts in which thymine glycol is bypassed by certain DNA polymerases in 
vitro
 [67]
   and in vivo 
[65]
. As Tg, like unmodified thymine, pairs with adenine it is a poor 
premutagenic lesion 
[64]
. If it is a simple thymine glycol lesion, it is removed via single 
nucleotide patch base excision repair pathway 
[77]
, but, if it accompanies a DSB   a more robust 
cell response to this damage may be required. 
Repair of the lesion is sequence 
[64, 70]
 and counter-base dependent. The counter base has the 
propensity to either block the replication or promote misinsertions during translesional synthesis. 
Damaged base repair enzymes, Endonuclease III 
[78]
 and its human orthologue hNHT1 via their 
bifunctional activity i.e., N-glycosylation and AP-Endonuclease activity, can release thymine 
glycol, producing a compatible DNA 3′ end. hNTH1 functions as the initial step of base excision 
repair(BER)   to repair the hydrated, reduced, or oxidized, from the DNA backbone
[79]
. 
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Fig 1.2: Formation of thymine glycol:  Reactive oxygen species (ROS), such as peroxide and 
hydroxyl radicals, are generated as byproducts during normal oxidative metabolism and ionizing 
radiation modify DNA bases. A common product of thymine oxidation is thymine glycol. Figure 
copied from Aller et al. 2007. 
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1.6 DNA Damage Response:   
 Sophisticated cellular networks that constantly monitor genome integrity are collectively termed 
the DNA damage response (DDR). DNA DSB’s are deleterious as there is no complementary 
strand to be used as a template for repair. Repair of these breaks is the function of two major 
pathways: Homologous recombination and Non-Homologous end joining repair. These repair 
pathways are complementary and function under different circumstances. As homologous repair 
requires a sister chromatid for template, it occurs in S andG2 phase of the cell cycle 
[80, 81]
.   
NHEJ is functional throughout the cell cycle and does not require a template. This makes NHEJ 
more error prone to insertions and deletions 
[82]
.   When classical NHEJ is impeded because of a 
missing or mutated component, alternative end-joining pathways operate. These alternative end-
joining pathways utilize the factors such as the MRE11–RAD50–NBS1 (MRN) complex, 
poly(ADP-ribose) polymerase-1 (PARP-1), XRCC1, and DNA Ligase I or III that are involved 
in SSB repair (SSBR) or HR and there is reliance on terminal micro-homologies for the joining 
reactions
[83]
.  
In response to DNA damage three distinct functionalities are activated: (1) Damage detection, (2) 
control of cell cycle and transcriptional programs of damage response, and (3) mechanisms for 
catalyzing the repair of the lesion 
[84]
. 
Cell cycle progression and DNA repair are tightly regulated via cell cycle checkpoints due to 
activation of orchestrated cell signaling pathways 
[85]
.  On detection of DNA damage, these 
pathways stall the cell cycle progression at crucial stages such as before or during DNA 
replication (G1/S and intra-S checkpoints) and before cell division (G2/M checkpoint), thereby 
preventing duplication and segregation of damaged DNA. MRN sensor complex detects DSB’s 
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and activates and recruits   apical DDR kinase ATM (ataxia telangiectasia mutated) 
[86] 
while 
RPA recruits the ATR (ATM and rad3-related) kinase via its partner protein, ATRIP (ATR-
interacting partner) at the regions of ssDNA exposed by DSB processing or ssDNA at stalled 
replication forks 
[87]
. Mediator proteins for ATM such as BRCA1, MDC1 (mediator of DNA 
damage checkpoint) and 53BP1 (p53-binding protein 1) activate the effector kinases Chk1 and 
Chk2, spreading the signal throughout the nucleus stalling the progression of cell cycle. Reports 
show that ATM inhibit both RNA polymerase I- and II-dependent transcription locally at sites of 
DNA breaks in human cells
[88, 89]
  and recruits DNA repair proteins. 
1.7 Repair Pathway Selection: 
The MRN complex plays a pivotal role in directing a DSB down the appropriate repair pathway, 
via its DNA end-processing activities 
[90, 91]
. In DDR, MRN complex responds very early and 
acts as a DSB’s sensor [92]. In addition, it functions as a co-activator of   cell cycle checkpoint 
signaling and a DSB repair effector in both the HR and NHEJ pathways 
[93-97]
. Resection at 
DSBs plays a central role in determining the result of the competition between HR and NHEJ. 
While NHEJ is functional at any phase of cell cycle 
[98]
, HR is active during S and G2 phase, 
suppressing NHEJ during these phases. The factor which directs MRN complex mediated 
pathway selection is CtIP.  CtIP concentrations are very low in G0/G1 phase, attributed to the 
proteosomal degradation during this phase. Upon progression to S/G2, CtIP protein levels are 
upregulated due to alleviation of this degradation 
[99]
. CtIP is phosphorylated at Ser327 position 
in a CDK-dependent fashion,   promoting complex formation between CtIP, MRN and BRCA1 
in S/G2 
[100]
. This binding of CtIP to MRN complex, confers it with the exonuclease activity, and 
thus triggers 5′→ 3′ resection via ExoI and 3′→5′ resection via Mre11 activity [100].  Following 
this initial processing, other nucleases and helicases produce further resection of DSB generating   
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extensive 3′ ssDNA overhangs on each side of the break [101- 103 ]. The ssDNA thus generated is 
an excellent substrate for the HR-specific ssDNA-binding factors RPA and Rad51 
[91]
, and a poor 
one for NHEJ-specific double strand DNA termini binding factor Ku70/80 
[104]. The 
phosphorylation state and low concentration of MRN-associated CtIP during G1 prevent the 5′ 
→ 3′ resection, prevents the formation of ssDNA and gives an opportunity for the NHEJ proteins 
to process the repair. 
 1.8 Homologous recombination: 
Homologous recombination is the DNA repair process which utilizes a homologous sequence,   a 
homologous chromosome or a sister chromatid for accurate DNA repair. This is a highly 
conservative process. As discussed above, the initial sensor and responder to localize at the DSB 
is the MRN complex 
[105]
 to form nuclear foci. MRN complex incites the further steps in HR 
mechanism by recruiting a phosphatidylinositol-3-related kinase, ATM, which phosphorylates 
histone H2AX at Ser139 position forming ϒH2AX. MDC1, a mediator protein facilitates the 
binding and phosphorylation between ATM and H2AX. By marking one or more megabases of 
DNA surrounding the break,   ϒH2AX serves as a molecular beacon signaling the presence of 
damage 
[116]
. ϒH2AX forms as a scaffold protein for the accumulation of other proteins in the 
repair pathway. Formation of NBS1/MRE11/Rad50, 53BP1, and BRCA1 foci is also regulated 
by MDC1.  The RING-finger ubiquitin ligase, RNF8, at its FHA domains interacts with 
phosphorylated MDC1 
[106-108]
.  RNF8 further ubiquitinylates H2AX and facilitates the 
accumulation of BRCA1 at the site of damage 
[109,110]
. BRCA1-C complex, BRCA1-CtIP, is 
formed by the direct interaction o BRCA-1 and phosphorylated CtIP, and is recruited by MRN 
complex 
[111]
. Cyclin dependent kinases   phosphorylation of CtIP on Ser327 is essential for 
physical interactions between CtIP and BRCA1, which occurs only during G2 phase of cycle 
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[112]
. CtIP enrichment at the DSB site is MRN and ATM dependent. Upon binding to the MRN 
complex, of CtIP catalyzes Mre11 endonuclease activity, to introduce nicks on the DNA 
duplexes as far as 300 nt from DSB ends. The nick thus produced triggers   Exo1-dependent 5′ -
3′  resection, while the Mre11 exonuclease mediates 3′ -5′ degradation of the nicked strand 
toward the break releasing any other proteins such as Ku(NHEJ factor) bound to the DSB, thus 
blocking NHEJ.. This extensive DSB end resection generates single strand DNA (ssDNA) 
overhangs 
[113,114]
. ssDNA binding complex RPA (replication protein A) coats these  ssDNA 
overhangs initially, later substituted  by RAD 51, forming a nucleoprotein filament. Other 
recombinant proteins such as RAD52/RAD54 stabilize this interaction. This RAD51 
nucleofilament, together with various other HR factors, mediates strand invasion near a 
homologous sequence in sister chromatid or homologous chromosome. Once the strand is copied 
and filled in by DNA polymerases and ligated by Ligase I, DNA helicase and resolvase enzymes 
mediate the cleavage and resolution of HR intermediates. 
1.9 Nonhomologous End Joining:  
NHEJ, as the name suggests, involves direct joining of the DNA ends with minimal processing 
of the ends. DSB repair in mammals appears to be primarily by NHEJ 
[132]
.   This mechanism is 
constitutively active throughout the cell cycle, although it is partially suppressed by certain HR 
factors in S/G2 
[115]
.  
The three main steps of NHEJ are: (I) DNA end recognition and assembly and stabilization of 
the NHEJ complex at the DNA double strand break; (II) Bridging of the DNA ends and 
promotion of end stability; (III) DNA end processing; and (IV) Ligation of the broken ends and 
dissolution of the NHEJ complex 
[116]
.  
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   XRCC5, XRCC6 and XRCC7 are the genes that encode some of the core NHEJ proteins that 
form DNA-dependent protein kinase (DNA-PK).  XRCC5 and XRCC6 encode the 80 and 70 
kDa subunits of the Ku70/80 heterodimer (the DNA-binding subunit of DNA-PK), and XRCC7 
encodes the 470 kDa DNA-catalytic subunit of protein kinase DNA-PKcs 
[117]
. In addition to the 
above factors, a heterodimer XRCC4/Ligase IV is required for ligation of the strands 
[118]
 and   
Cerrunnos/XLF as an activator of ligase activity
 [119]
. 
Various end processing factors such as Artemis, TdT, WRN, PNK, hTDP1, FEN1 are required to 
clean the ends of the DNA of any factors that hinders the direct joining and DNA polymerase λ 
for filling the gaps created in the process.  Proteins such as PARP-3 and APLF accelerate the 
NHEJ by retaining the XRCC4/Ligase-IV complex at the site of break 
[120]
. 
1.10 NHEJ Pathway: 
DSB associated with V (D)J recombination, irradiation or chemotherapy damage  are primarily 
recognized by the MRN complex, which by further signaling via ATM, phosphorylates and 
activates H2AX to ϒH2AX. ϒH2AX recruits BRCA-1 or 53bp1, one of the deciding factors for 
the type of repair.  In G1/M oligomers of 53bp1 flank on the either side of the DSB bound to the 
histones modified by acetylases and methyl transferases. The chromatin conformation is thus 
maintained,   with limited access to transcription and HR factors 
[121]
, promoting NHEJ. 
Whenever there is a DSB, irrespective of the cell cycle Ku is the initial protein 
[122] 
to
 
translocate 
to the site and binds dsDNA ends with extremely high affinity 
[82]
 and encircles the DNA with its 
preformed channel 
[123]
. This binding occurs in an ATP dependent manner 
[104]
 and prevents the  
DNA ends from further damage. Ku functions as a signal molecule for the recruitment of further 
NHEJ proteins. Recently, it has been shown that Ku can process the ends of the DNA by the 
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virtue of its   5′-dRP/AP lyase activity, removing the abasic sites by nicking DNA 3′ of the abasic 
site which involves a Schiff-base covalent intermediate
 [124]
. After its binding to the ends, there 
will be inward translocation of Ku and recruitment of DNA-PKcs, to form a Ku-DNA-PKcs 
synaptic complex(DNAPK) which tethers the DNA ends together and offers protection from 
premature nucleolytic degradation 
[125, 126]
. Synapsis of the juxtaposed DNA ends stimulates auto 
phosphorylation of DNAPKcs by DNA-PK kinase activity, induces a conformational change in 
the DNA-Protein complex, providing access to nucleases and ligases as DNA-PKcs moves away 
[126-128]
. As the IR produces complex DSB’s with 3′-phosphate or 3′-phosphoglycolate groups, 3′ 
and 5′ overhangs with damaged bases and/or ribose units in the vicinity of the break ends [129, 130], 
the DNA ends must be processed prior to ligation. Enzymes, such as Artemis, FEN-1, PNKP, 
WRN, MRN, hTDP1, Polymerases belonging to Pol X family aid in the processing step.  
Artemis removes the hairpin bend at the end at the V(D)J associated DSB, metnase trims the 
damaged ends
[131]
,   nucleases remove several nucleotides from single-stranded overhangs at the 
DSB ends termini,   aprataxin   removes adenylate groups
[132,133]
 , the phosphodiesterases TDP1 
and TDP2 process DNA topoisomerase adducts
[134]
. DNA polymerases belonging PolX family 
fill in the gap. Mre11/Rad50/ Nbs1 (MRN) complex plays a role in damage signaling and 
protection of the ends from degradation 
[135]
   Khanna et al., 2001). FEN-1 has an exonuclease 
function; WRN (Werner syndrome helicase) and BLM (Bloom syndrome helicase) are the 
unwinding enzymes 
[136]
. 
In addition to DNAPKcs, DNA bound Ku also recruits XRCC4/Ligase IV complex and XLF 
independently 
[137]
. The recruitment of the proteins does not require any protein-protein 
interactions but the assembly of the proteins does. XRCC4 requires DNAPKcs and XLF requires 
XRCC4 to be retained at the repair loci. Once recruited, XLF and XRCC4 form a nucleo-
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filament around the DNA ends by interacting in a head-head manner. The architectural channel 
thus formed with the synergy of Ku-XLF-XRCC4 interaction stabilizes DSBs and provides 
accessibility and activation of LigIV, which ligates the DNA, ends
 [138]
.  Other proteins recruited 
to the DSB such as Aprataxin and-PNK-like factor (APLF) enhance the stability of the filament 
[133,139,140]
. As expected of it, NHEJ is an error prone pathway 
[141]
, as there will be often removal 
of the nucleotides and fill in without the guidance of a template. Loss of nucleotides during the 
process makes the DSB repair inaccurate.  Except for the recruitment of the Ku heterodimer, the 
order of recruitment of other factors is flexible depending on the complexity of the DNA damage 
[142]
.  The recruitment of the NHEJ machinery to the site of the DSB occurs via a dynamic 
assembly 
[137,143]
, rather than a step-wise sequential manner. Simple Ku heterodimer, XRCC4, 
LigaseIV and XLF are sufficient for the repair of simple DSB, whereas complex breaks requires 
DNA-PKcs and ATM activation. 
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                                                                                   Emil Mladenov and George Iliakis, 2011  
Fig: 1.3: Schematic overview of NHEJ: 1) Recognition of the DSB produced by an  by the 
heterodimer protein Ku  2) Recruitment of the DNA PKcs by Ku and formation of DNA PK 
complex by the activation of its kinase activity 3) Autophosphorylation of DNA PKcs shifts the 
complex inwards exposing the DNA ends for the processing enzymes.  4) XRCC4/LigIV 
complex in combination with XLF forms a filament around the broken ends and once the ends 
are processed DNA LigIV ligates the ends restoring the DNA integrity. 
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NHEJ Proteins: 
1.10.1 Ku Protein: 
Ku is the first of the core NHEJ proteins to sense the DSB and initiate the repair
[144]
. The protein 
occurs in abundance and binds to the DNA ends with a strong binding constant of 2×10
9 
M
−1
. Ku 
protein exists as a heterodimer, composed of a 73 kDa subunit (Ku70) and an 86 kDa subunit 
(Ku80). Ku70 and Ku80 share similarity in the central DNA binding region(Ku core), with 
unique carboxy and amino-terminal regions. Ku heterodimer binds to the ends of the DNA in an 
ATP dependent manner with high affinity
[109,124]
. The  three-dimensional structures of both 
subunits, have regions that  contribute to a basket structure to completely encircle the dsDNA 
molecule
[123]
. Binding site for Ku on DNA is the sugar back bone and thus sequence 
independent
[123]
. Though there can be binding of multiple Ku proteins on to the DNA in a length 
dependant manner in-vitro
[146,147]
, only a single heterodimer can bind to each end in vivo
[148]
. At 
the two DNA ends of the break Ku binds to each of them forming a Ku: DNA complex. This 
serves as a dock for further NHEJ protein assembly
[149]
. The Ku heterodimer, either directly or 
indirectly, recruits the main NHEJ factors, including DNA-PKcs
[145]
, X-ray cross complementing 
protein 4 (XRCC4) 
[150,151]
, DNA Ligase IV 
[150]
, XRCC4-like factor (XLF) 
[152]
, and Aprataxin-
and-PNK-like factor (APLF) 
[139, 140, 153]
 to DSBs. Ku undergoes a structural conformation in 
order to interact with DNAPKcs
[154]
, polymerases mu and lambda and  XRCC4:DNA ligase 
IV
[151, 154]
. On recruitment, binding and activation of DNA-PKcs by the Ku-DNA complex they 
form  “DNA-PK” complex[156] . There is activation of its kinase activity which phosphorylates 
four sites in the unique regions on Ku : serine at 6 th position of Ku70 and serine 577, serine 580  
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and threonine 715 sites of Ku80 
[157]
 and various other NHEJ proteins.  Protein- protein 
interactions are promoted by the putative von Willebrand (vWA) domains on Ku 70 and Ku 80.  
SAP domain (SAF-A/B, Acinus and PIAS), a putative DNA-binding motif on the carboxy-
termini of Ku70 proteins is important in chromosomal organization.  Ku 70  interacts with  
XRCC4 directly
[144]
 and  the heterodimer with DNA ligase IV in a DNA dependent manner via 
its tandem BRCA1 C-terminal (BRCT) domains found in C-terminus of DNA Ligase
[150]
. The 
binding of XLF to the Ku heterodimer is also in a DNA dependant fashion mediated between the 
heterodimeric domain of Ku and the C-terminal region of XLF from amino acids 270–299 [158]. 
The protein APLF which stabilizes the NHEJ complex, interacts  at its  conserved MID domain ( 
182–191),  directly with the vWA domain of Ku80 [192].  Structurally, the Ku heterodimer 
performs  a general role in binding to and maintaining the stability of the ends at DSBs in all cell 
cycle phases 
[159]
. By maintaing the two ends of the broken DNA molecule together in a synaptic 
complex, it produces positional stability in both in vitro and  in vivo 
[146,160,161]
. Ku protein also 
blocks the  DNA end processing enzymes including exonuclease 1 and the Mre11/Rad50/Nbs1 
complex in vitro 
[162]
.  Recently discovered enzymatic activity of Ku is 3′-dRP/AP lyase that 
removes abasic sites by nicking DNA 3′ of the abasic site, catalyzed via Several lysine residues 
in the Ku70 vWA domain
[124]
. 
In a treatment with combination of camptothecin and   ataxia-telangiectasia mutated (ATM) 
protein inhibitors 
[148]
 or treatment of HR-deficient cells with Poly (ADP-ribose) polymerase 
(PARP) inhibitors 
[165]
 or in treatment of Fanconi Anemia (FA)-deficient cells 
[164]
, Ku mediated 
NHEJ is required to kill the cells.  
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Fig 1.4: Schematic representation Ku heterodimer subunits 70 and 80 with the common “Ku 
core” regions of Ku70 (amino acids 261–505) and Ku80 (amino acids 251–509), vWA at the 
Ku70 (amino acids 37–260) and Ku80 (amino acids 9–235) , phosphorylation sites Ku70 (serine-
6) and Ku80 (serines 577 and 580 and threonine 715)  indicated by “P” and DNA-PKcs 
interacting region  (amino acids 720–732) on Ku80, SAP domain in Ku70 (amino acids 559–
609) and a Nuclear Localization Signal domain.        S.P. Lees-Miller, K. Meek 2003 
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1.10.2 DNA-PKcs 
  DNA-PKcs is a serine/threonine protein kinase, a member of the phosphatidylinositol-3 kinase 
related protein kinases (PIKKs) 
[166-168]
. The   DNA-PKcs tertiary structure, as determined by the 
Cryo-electron micrograph studies is composed of a globular head or crown region and a tail or 
base 
[169-171]
, with cavities large enough to accommodate dsDNA. It is composed of a large 
catalytic subunit, DNA-PKcs (encoded by the gene PRKDC), and a heterodimeric protein, Ku.  
Like the other PIKKs it has a carboxyl-terminal PI 3, 4-kinase domain. Flanking the kinase 
domain are a large amino-terminal domain and FAT (FRAP, ATM, TRRAP) and FATC domains 
[172]
. The FAT and FATC domains may interact to stabilize the catalytic domain. The large N 
terminal domains have a highly helical surface that could provide multiple sites for protein–
protein interactions 
[173]
.  
 At the DSB, Ku70/80 heterodimer  recruits  DNA-PKcs to the DNA ends to form the DNA-PK 
holoenzyme and activates the kinase activity of DNA-PKcs. Activated DNA PKcs can 
phosphorylate each of the canonical NHEJ factors including Ku70/80 
[157,175]
, XRCC4 
[176,177]
, 
DNA Ligase IV 
[178]
, and XLF 
[179]
, in vitro, though not essential for their function.  Other factors 
such as Artemis, polynucleotide kinase/phosphatase (PNKP), the histone H2AX and p53 are also 
phosphorylated  in a redundant  manner by both DNA PKcs and ATM
[180-182]
. DNA-PKcs has no 
to limited kinase activity in the absence of Ku70/80 and DNA, thus making it truly a DNA-
dependent protein kinase 
[183,184]
. Both autophosphorylation and transphosphorylation of the 
DNAPKcs can occur as a function of the DNA damage response
[185,186]
. Autophosphorylation at 
the DNA-PKcs S2056 cluster of DNA-PKcs is required for relieving the blockade
[186]
 it creates 
for the formation of XRRC4-XLF filament across the DNA break
[185, 187, 188]
, thus allowing the 
end ligation to occur. Transphosphorylation at the T2609 clusters on DNAPKcs by ATM 
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primarily required the recruitment of Artemis endonuclease to open the hair pin bends at the 
DNA ends. ATR mediated phosphorylation also promotes end processing.  DNAPKcs can 
phosphorylate the other self-molecule at the same cluster as ATM. Studies show that the protein  
with  mutation at three of the five potential phosphorylation sites with in the T2609 cluster(3A 
allele) does not block hairpin opening, but renders it hypersensitive to both ATM and DNA-PK 
kinase inhibitors
[189]
.   The DNAPKcs null mice are viable but immunodeficient, and human cell 
lines such as M059J with frame shift mutations of DNAPKcs 
[190,191]
 lack kinase activity 
[192]
, 
rendering them radiosensitive
[193]
.  
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Fig 1.5 Schematic representation of DNA PKcs showing the FAT (FRAP, ATM, TRRAP), 
FATC domains , kinase domain and the phosphorylation sites. Davis et al. 2014. 
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1.10.3  XRCC4/DNA Ligase IV: 
 After processing of the DSB ends  by nucleases and polymerases, the terminal and the central 
joining step of NHEJ is carried out by XRCC4-DNA Ligase IV complex.  XRCC4 – X-Ray 
Cross Complementing protein -4 interacts and forms a tight complex with  DNA ligase IV 
[118,194,195]
 and this complex, often referred to  as X4L4 
[224]
. This complex is formed in  the 
cytoplasm and localized to the nucleus in response to DSB
[243]
. During this localization process 
XLF is also recruited
[243]
. XRCC4 protein is a tetramer resembling a dumbbell with two globular 
ends separated by a long thin stalk.   The tetramer is composed of two dimers, and each dimer is 
made up of two similar subunits. The first subunit (L) contains amino acid residues 1 – 203 and 
has a longer stalk than the second subunit (S) which contains residues 1 – 178. These two 
subunits share similarity in the globular N-terminal domains. XRCC4 can interacts with DNA 
[196]
, DNA-PKcs 
[197]
, Ku 
[157]
 and DNA polymerase μ [198].  Upon recruitment of XRCC4 and 
XLF to the site of DSB,  these proteins interact co-operatively  to form nucleoprotein super 
helical filaments via alternating XRCC4 and XLF head domains. The interface of the  filament 
interacts and bridges the ends of the broken DNA
[199-201]
. Hyper-phosphorylation by DNA-PKcs 
at the C-terminal alpha helical domains of XRCC4 facilitates this interaction.  The so formed 
filament interacts with the DNA at the positively charged surfaces formed by conserved 
lysine/arginine clusters, XRCC4: Arg-71, Lys-72, Lys-99, Lys-102, and Arg-107; XLF: Lys-31, 
Arg-57, Lys-59, Lys-63, Arg-64, Arg-81, Arg-107, and Arg-109)
[202,203]
.  XRCC4/LigaseIV 
complex is formed by the interaction of BRCT2 domain of Lig IV at the C-terminal stalk of 
XRCC4 via multiple residues, enhanced by the Cernunnos(XLF)
[199]
. DNA Ligase IV is specific 
to c-NHEJ and  is an ATP-dependent  DNA ligase (ATP-dependent transfer of phosphate bonds 
that results in strand ligation) 
[204]
.  Ligase IV at its N-terminus,  carries a  DNA binding 
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domain(DBD) with  an adenylation domain that has the active site of the enzyme and an oligo-
binding domain (OBD)
[204]
. At the  C-terminus, it has two breast and ovarian cancer 
susceptibility protein C-terminus (BRCT) domains separated by a linker containing the XRCC4-
interacting region (XIR). DNA Ligase IV is capable of  ligating  incompatible DNA ends and 
DNA across gaps
[205]
. LigIV is recruited to DSBs through its interaction with the stalk of XRCC4 
[206,207]
. Ligase IV protein is not stable in XRCC4-deficient cells, either in mammals or 
yeast
[208,209]
. Though DNA ligase IV has activity on its own, its interaction with the XRCC4 
stimulates Ligase IV  activity by the stabilization and adenylation 
[194] 
.   Ligase IV mediated 
ligation of the mismatched and non-cohesive ends is facilitated by XLF. By promoting   
readenylation, XLF also primes DNA Ligase for the next ligation event 
[210-213]
. APLF protein 
was recently proved to stimulate ligation by XRCC4-DNA LigaseIV only in the presence of 
Ku70/80 
[139]
. Studies show that localization of XRCC4 and XLF to the DNA and the formation 
of filaments depends Ligase IV 
[214,215]
. And  formation of  Ligase IV/XRCC4 complex is needed 
for the efficient interaction of XLF with XRCC4 
[215]
. In addition, Ligase IV/XRCC4 complex 
contributes to DNA-PKcs autophosphorylation, DNA end synapsis 
[216]
  and recruiting and  
modulating the activity of nucleases and polymerases thus aiding in  processing  of the ends
[204, 
217–219]
. As with the other NHEJ proteins, mutations of  the  XRCC4/Ligase IV   result  in 
immunodeficiency and increased  IR sensitivity due to the dysregulated NHEJ 
[220]
.     
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Fig 1.6: Schematic representation of XRCC4 showing core functional and homodimerization 
domains of XRCC4 as well as the ligase IV binding region. Adapted from Kara et al. 2005 
 
 
 
Fig 1.7: Schematic representation of LigasIV showing the DBD, catalytic domain, NLS, BRCT I, 
XIR and BRCT II   Adapted from D.B. Francis et al. 2014 
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1.10.4 XLF: 
XRCC4-like factor (XLF),  also known as Non-homologous end-joining factor 1 (NHEJ1) and 
Cernunnos, is a novel protein encoded by the NHEJ1 gene
[221]
.
 
It is named as XLF due its 
similarity of the tertiary structure to XRCC-4 rather than the sequence homology
[222]
. XLF is a 
constitutive dimer with a N-terminal globular head, an alpha-helical stalk and a compact folded 
C-terminal region
[202]
.  XLF has no enzymatic function. It interacts with DNA, XRCC4, Ku and 
Ligase IV. XLF interacts with DNA in a length dependant and protein concentration dependent 
manner 
[119,202,211]
 at Lys-31, Arg-57, Lys-59, Lys-63, Arg-64, Arg-81, Arg-107, and Arg-109 
along with the XRCC4 residues Arg-71, Lys-72, Lys-99, Lys-102, and Arg-107 in its 
filamentous forms
[202,203]
.  XLF and XRCC4  interact in a head-head fashion at residues Leu-115 
residues of XLF and Met-59, Met-61, Lys-65, Lys-99, Leu-108, and Phe-10 of XRCC4   forming 
a “Leu-lock”[202]. These two proteins form long super-helical filaments that interact in parallel to 
form a grooved U-shaped channel
[200]
. XRCC4/XLF head domains form the base and the stalks 
of the proteins form the sides 
[223]
. DNA-PK complex phosphorylates XLF at C-terminal sites in 
vitro aiding the ability of the XRCC4:XLF filaments to bridge DNA molecules in C-NHEJ or 
V(D)J recombination
[224]
.  Studies show that XLF requires a DNA of 83 bp or longer to bind and 
cannot form  a stable complex with 60 bp DNA, in gel shift assays
[211]
. But  in the presence of 
Ku, XLF can form a stable complex with shorter DNA
[152]
. The 10 terminal residues in 
XLF(289–299) interact with the central DNA binding domain of the Ku heterodimer[152]. XLF 
once recruited and bound to XRCC4 enhances  the activity of  DNA ligase IV by  20–200-fold ( 
in vitro) 
[119,211, 212]
, especially  at mis-matched DNA ends 
[264]
. XLF may enhance ligation by 
promoting re-adenylation of LigIV 
[225]
. In response to the damage in the DNA,  XLF responds 
quickly and starts to accumulate locally  within a few seconds 
[137]
 in a Ku-dependent and 
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XRCC4-independent reaction. IR sensitivity was detected in XLF deficient human fibroblasts 
[210,213]
 and mouse ES cells 
[226]
 along with  DSB repair defects and  severely impaired V(D)J 
recombination. The first clinical case of SCID due to XLF deficiency was reported in 2003
[227]
. 
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Fig 1.8: Structure of the human Cernunnos/XLF protein. (A) Schematic representation of the 
full-length Cernunnos/XLF protein (299 amino acids). Clinically and functionally important 
residues are shown. NLS means a nuclear localization signal. A gray region represents the N-
terminal globular domain. Adapted from Yoni et al. 2009 
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1.11  Base Excision repair pathway 
Oxidative DNA damage can result   from the attack by reactive oxygen and nitrogen species 
(ROS/RNS)  which can be produced by either exogenous sources of oxidation such as ionizing 
radiations like X, γ and cosmic rays, radon decay, oxidizing chemicals and UV-A solar light[228] 
or endogenous O2 metabolism (electron transport chain (ETC)), immune responses and 
inflammation
[229]
.  This includes base modifications such as oxidized bases, abasic (AP) sites, 
and single-strand breaks (SSBs). BER is the primary nuclear and mitochondrial DNA repair 
pathway for small base modifications such as alkylation, deamination and oxidation
[230]
. It 
predominantly processes small base lesions derived from oxidation, alkylating agents and 
genotoxic chemicals
[231]
. The BER pathway functions in five steps utilizing four main enzymes, 
DNA glycosylase (DG), AP endonuclease (APE1), DNA polymerase and DNA ligases
[231,232]
. 
Other essential proteins that are required for the repair are X-ray repair cross-complementing 1 
(XRCC1); proliferating cell nuclear antigen (PCNA); replication protein A (RPA)
[233]   
(Mitra et 
al., 2001) and poly ADP ribose polymerase-1 (PARP1).  The  poly ADP ribose polymerase-1 
(PARP1) and X-ray repair cross-complementing protein 1 (XRCC1) 
[234–238]
 are the two major 
scaffolding proteins in BER.  The repair pathway proceeds through five steps. First step is the 
recognition and removal of the damaged base, which is performed as a function of glycosylases 
such as  uracil/thymine excision enzymes (UNG, SMUG1, TDG, and MBD4) 
[239,240]
, 8-oxo-G 
repair enzymes (OGG1 and MYH) 
[241, 242]
, oxidized pyrimidine repair enzymes (NTH1 and 
NEIL1–3) [243-244] and methyl-purine glycosylase (MPG) [245, 246]. The glycosylation leaves an 
abasic site which can stall transcription and must be processed for the repair to continue
[247, 248]
. 
This apurinic/apyramidinic site is cleaved by the DG itself, if it is bifunctional
[249,250]
 or by 
APE1, if DG is monofunctional
[233, 251, 252]
. After the removal of the abasic sugar, the strand 
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break formed is  proximated by the scaffolding proteins poly ADP ribose polymerase-1 (PARP1) 
and X-ray repair cross-complementing protein 1 (XRCC1) 
[234-238]
. There is further recruitment 
of the other BER proteins, required for the completion of the repair 
[234-238]
. 
The fourth step is clearing of the 3′ block formed by 3′ phosphoglycolates, by APE1 and/or 
PNKP or Pol β and addition of 5′ phosphate groups by 5′  polynucleotide kinase (PNK) in an 
XRCC-1 and DNA-PKCS-dependent manner
[253]
. As the ends are cleaned and made compatible 
for ligation, DNA polymerase-β (pol-β) fills in the gaps[254]. The insertion can be either a single 
base  (short-patch repair)  or   a stretch of bases inserted at and beyond the initial site of damage 
(long-patch repair) displacing some of the nearby bases
[255]
. These displaced stretch of DNA 
bases are cleaved by a specialized flap-endonuclease, FEN1 
[256]
. Finally, the nick created is 
sealed by DNA Ligase, DNA ligase I (LIGI, long-patch BER) or DNA ligase III (LIGIII, short-
patch BER)
 [257] 
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                                                                                                    A.K. Mantha et al. 2014 
Fig. 1.9:  Oxidative DNA base damage repair through BER-pathway. Initiation of BER is  by 
removal of the modified base by either a monofunctional (M) or bifunctional (B) DNA 
glycosylase (DG), which leaves an AP site. If monofunctional enzyme cleaves the glycosidic 
bond APE 1 incises the DNA backbone 5′ to the AP site. The single strand breaks(SSBs) left by 
the both DG and MG contain either a 3′ or 5′ obstructive termini. These end breaks are 
recognized by PARP1and processed by pol-β, APE1 or PNKP depending on the specific nature 
of the terminus.  When 3′-OH and 5′-P termini result from end processing, the BER and SSBR 
diverge into two sub-pathways, short-patch (SN) and long-patch (LP) BER/SSBR. In SN-
BER/SSBR, the single nucleotide gap is filled in is  pol β aided by the XRCC1 scaffold in the 
presence of PNKP and ligated by Lig III. In LP-BER/SSBR, pol δ/ε with the aid of  PCNA  2 to 
13 nucleotide gap is  filled in and the   resulting 5′ flap is removed by FEN-1. As with the SN-
BER final ligation step is accomplished by Lig I. 
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1.12 Human EndoIII like protein (NTH) and bacterial Endonuclease III 
EndoIII like protein (NTH) is   the major human DNA glycosylase that detects and removes the 
oxidized bases by its N-glycosylase activity 
(258)
 as the first step in base excision repair pathway 
(BER). Thymine glycol is one of the substrates 
(259)
. However, some studies documented that if 
the oxidative bases are located at the 3′ terminal position of a SSB, that activity of NTH1 is 
greatly reduced 
(260,261)
. Many genes encode enzymes that are involved in the repair of damaged 
bases that are evolutionally conserved in many species ranging from bacteria to human 
(262)
 
Endonuclease III (Nth) is a bifunctional enzyme from E. coli that acts as both an N-glycosylase 
and an AP-lyase. While the N-glycosylase activity releases damaged pyrimidines from double-
stranded DNA, generating an abasic site (an apyrimidinic or AP site), AP-lyase activity of the 
enzyme cleaves 3′ to the AP site, leaving a 5′ phosphate and a 3′ ring-opened sugar. Urea, 
thymine glycol and uracil glycol are the damaged bases recognized and removed by 
Endonuclease III   
(263,264)
.                       
1.13 Klenow Fragment:  
DNA polymerase I (Pol I) is encoded by PolA gene (928bp) has 5′-3′ exonuclease activity (1–
323), 5′-3′ polymerase activity (324–517) and 3′ -5′ exonuclease activity (521–928). Klenow 
fragment is the large protein fragment (324-928) and is produced from DNA Pol I by proteolysis 
with protease subtilisin, losing its 5′-3′ exonuclease activity and retaining the polymerase and 3′-
5′ exonuclease activity. It functions in synthesis of double-stranded DNA from single-stranded 
templates, fills in recessed 3′ ends of DNA fragments to make 5′  overhang blunt by digests away 
protruding 3′ overhangs. Mutation in the region with 5′-3′ exonuclease activity retains only 5′-3′ 
polymerase activity, producing a Klenow Exo- fragment. Klenow Exo- can only polymerize  
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the strand in 5′-3′ direction on a single strand of DNA or at the end with a 5′ overhang. It has also 
the ability to add an extra nucleotide to the 3′   terminus of a blunt end because of the absence of 
exonuclease activity. 
Studies show that presence of thymine glycol in the clustered DNA lesions influences the repair 
of these lesions. If Tg is opposed to the AP lesion in a bistranded cluster damage there is a 
substantial delay in the repair of the AP lesion by short BER
[265]
 Presence of Tg at the DSB with 
the overhangs, inhibit the gap filling by polymerases, due to its planar structure
[266]
.  The current 
study focuses on the tolerance of the presence of the Tg at the DSB blunt ends by NHEJ repair in 
cell extracts and core recombinant NHEJ proteins. 
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                                         II. MATERIALS AND METHODS 
 
 
2.1 Substrate 
Theoligonucleotides5′ATGCGGATCGCGTTGTCTg (Tg1), 5′ATGCGGATCGCGTTGCTgC 
(Tg2), 5′ATGCGGATCGCGTTG-Tg-CT-3′ (Tg3) and 5′-ATGCGGATCGCGT-Tg-GT CT-3′ 
(Tg5) were ordered from Midland Certified Reagents (Midland, TX).  They were re-suspended 
in TE (10 mM Tris–HCl, pH 8, and 0.1 mM EDTA). 1mCi of [γ-32P] ATP was used to label 50 
pmoles of the oligonucleotide, using Polynucleotide kinase (PNK) and incubated for 1 hr at 37 
°C. Each oligomer was then annealed to an equal quantity of a complementary 5′- phosphate 
containing, 3′GTATACGCCTAGCGCAACGAGp5′ or 3′GTATACGCCTAGCGCAACAGAp-
5′, via heating to 80°C followed by slow cooling to10°C. The duplexes generated by this 
annealing process included, on one end a 3-base 3′overhang that was complementary to the 3′ 
overhang created by BstAPI digestion of pUC19.   
2.2 Ligation of oligomeric duplexes to the KasI/BstAPI cleaved pUC19: 
17μg of the plasmid pUC19 DNA is digested with 50 units of KasI (NEB) in 0.3 ml of NEB 
CutSmart buffer for 3 hrs at 37°C and then digested with 50 units of BstAPI in the same buffer 
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for 3 hrs at 60°C. The 2.6-kb KasI-BstAPI fragment was purified on a 0.8% agarose gel, electro 
eluted and concentrated with an ultracel 100k centrifugal filter.  
      10 pmole of the annealed oligomers were combined with (~1.7 pmole) of KasI/BstAPI 
fragment and treated with 12,000 units (4 μl) T7 DNA ligase in to ligate them at the BstAPI end 
in 130μl of ligation buffer for 2 hrs at 25°C. Phenol/chloroform and ethanol precipitated 
extraction of the ligation products is done. These products are then digested with SmaI (500 
units) for 2 hours at 25°C in 50 μl CutSmart buffer. This removes 177 bp from the KasI-end and 
leaves a blunt end. The resulting 2.6-kb substrate has one Tg-modified end. This substrate is 
electro eluted and concentrated as above. T7 ligase was used for ligase instead of T4 ligase due 
to its preferential ligation of only cohesive and not the blunt ends (Doherty at al. 1996; 
Subramanya et al.1996). Some self-ligation was detected in case of the unmodified control 
oligomers, and therefore for these oligomers the T7 Ligase was reduced to only 2400 units. In 
the case of Tg5 plasmid there some ligation seen between head-head blunt ends, and cutting the 
plasmid with Sma I would have eliminated any head-tail ligation. The ligation products were 
purified by agarose gel electrophoresis and Electro elution (Bennett et al. 1996).   
2.3 Electro elution of the modified substrate: 
The nucleotide is electro eluted using a 11 inch segment of pretreated dialysis tubing (6,000-
8,000 molecular weight) filled with the buffer composed of 20mM Tris, pH8 and 1mM EDTA 
(the elution buffer). The gel slice containing the desired DNA band was placed in the dialysis 
tubing and the other end of it was knotted after removal of air bubbles. The dialysis tube was 
placed in a gel box filled with the same buffer and the DNA was eluted overnight at 50 V.  Then 
the dialysis bag was cut and the buffer containing DNA substrate was collected into 15 ml 
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centrifuge tubes. 0.45μm filters were used to remove any debris and the DNA was concentrated 
by micro- concentration to about 500 μl using centricon-100 (Amicon). The concentrate was 
collected into 1.5 ml Eppendorf tubes and precipitated with 1/9 volumes of NaOAc and 2.5 
volumes of 100% EtOH, washed with 70% EtOH and dissolved in 50 μl TE. 
2.4 Bus cell extract preparation: 
      Bus cells were grown in to confluence on thirty 15-cm dishes each with 20 ml alpha-MEM 
medium with 10% FBS. On the day of the experiment, the dishes were washed with 20 ml PBS 
at room temperature. 3ml of 0.25% trypsin-EDTA was added to each dish, making sure it covers 
all the cells. They were incubated for 5 min until the cells are detached and then 3 ml medium 
and serum were added. These samples were collected and pelleted in 50 ml tubes at 1500 rpm for 
5 min in ultracentrifuge using SW55 rotor at room temperature. The cells were resuspended in 50 
ml medium and serum and pelleted again. The pellet was again resuspended in 25 ml medium 
and serum and pelleted again. The pellet was resuspended in 30 ml ice cold PBS and pelleted at 
4
°
C and packed cell volume (PCV) is recorded. The last process was repeated again. The pelleted 
cells were resuspended in 5XPCV cold hypotonic buffer containing10Mm Tris-HCl pH8, 1mM 
EDTA, 5mM DTT and proteinase inhibitors pepstatin 1μg/ml, chymostatin 1μg/ml, aprotinin 
2μg/ml, leupeptin 1μg/ml, PMSF 1mM.  The cells were quickly pelleted. This pellet was again 
resuspended in 2XPCV hypotonic buffer and inhibitors and let set on ice 20 min. 1.5 ml of this 
solution was put in a small dounce homogenizer each time and stroked 20 times. After it was let 
set for 20 min, it was transferred to cold 5 ml centrifuge and ¼ volume of the hypertonic solution 
( 83.5Mm Tris Ph 7.5, 1.65M KCl, 3.3 mM EDTA, 1mM DTT) and inverted several times to 
mix well. This was centrifuged at 43K for 3 hrs in SW55 at 2°C. From the top the middle layer 
which has cytosol was collected using 22G needle, avoiding cloudy layer on the top. The 
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cytoplasm thus collected was dialyzed for 3 hrs in storage buffer (20Mm Tris pH 8, 0.1 M 
KOAC, 1Mm DTT, 0.5Mm EDTA, 20% glycerol) with inhibitors at 4°C. The resulting solution 
was freezed in small aliquots(10μl-80μl) at -80°C. 
2.5 End joining assays using cell extracts: 
Bus whole cell extracts which are deficient in XLF were used for the reactions in a buffer 
containing 50 mM triethanolammonium acetate (pH8), 1 mM ATP, 1 mM dithiothreitol, 50 
μg/ml BSA , 1.3 mM Mg(OAc)2 and dNTPs at 100 μM each. 
Total reaction volume was 16-μl, with 10μl of extract, resulting in a final protein concentration 
of 8 mg/ml. 200nM of human recombinant protein XLF was substituted for some reactions.  100 
ng of the substrate was added and the reaction mixed by pipetting and incubated at 37 °C for 6 
hrs. Samples were deproteinized by adding an End Joining Lysis buffer containing 1mg/ml of 
Proteinase K for 3 hrs at 56°C. The DNA was then extracted with phenol/chloroform and 
precipitated with glycoblue and ethanol for one hour. After the   precipitation, all samples were 
dissolved in 43 μl of TE and digested with 20 units of NdeI and PstI and 5 μl of 10X CutSmart 
buffer (New England Biolabs) at 37°C for 3 hrs. Gel electrophoresis of the samples was done in 
20% polyacrylamide sequencing gels. Then the gels were exposed to phosphor imaging screen 
for1 to 2 days at -20°C.  Data were analyzed using a Typhoon 9100 imager (GE Healthcare Bio-
Sciences, Pittsburgh) and Image Quant 3.1 or 5.1software (GE Healthcare Bio-Sciences, 
Pittsburgh). The percentage of end joining was determined by measuring the percentage 
radioactivity of the joined fragments as a function of total radioactivity in the same lane. 
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2.6 Polyacrylamide gel electrophoresis: 
For electrophoretic separation of the DNA strands, Polyacrylamide gels (20x30x0.08cm)   
containing 40% acrylamide: bisacrylamide in a ratio of 20:1, 8μl of 10XTBE and urea in a final 
concentration of 8.3 M were used. The mixture was cooled to room temperature and 0.06g 
ammonium persulfate and 45μl of TEMED (N’, N’, N’, N’-tetramethylethylene diamine) was 
added. The gel was allowed to polymerize for 1 hour. 15 μl of samples are then loaded into the 
wells of the gel and electrophoresed at constant power of 42 W until the marker reached the 
bottom of the gel. 
2.7 End joining reaction with ddTTP and Endonuclease: 
Bus cell extracts were substituted with XLF and ddTTP was used instead of dTTP during the 
incubation for some end joining reactions. After proteolysis and phenol/ethanol precipitation, 
each of the reactions with dTTP and ddTTP was divided into equal halves. One half was treated 
with Endonuclease III in Endonuclease III buffer for 2 hrs at 37°C, while the other half served as 
a control. After inactivation of endonuclease at 65
°
C for 20 min, the reactions were treated with 
NdeI and PstI and analyzed on the 20% polyacrylamide sequencing gels the same way as above. 
2.8 Klenow Enzymes treatment: 
The joined plasmids in the Bus cell extracts substituted with XLF were treated with Klenow and 
Klenow exonuclease
- 
with the addition of 1 mM ATP, dNTPs at 100 μM and 5μl CutSmart 
buffer for 30 min at 37°C, after the proteolysis and phenol/ethanol precipitation. After 
inactivation at 75°C for 20 min and phenol/ethanol precipitation, the reaction is digested with 
NdeI and PstI, and then analyzed on 20% polyacrylamide sequencing gels. 
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2.9 End joining by the recombinant proteins: 
Ligation of the above prepared substrates was attempted using recombinant NHEJ proteins in a 
buffer containing 50mM Tris pH8, 200m, 100μg/ml BSA, 0.2Mm EDTA,0.1% Triton, 4mM 
DTT and 10% Poly ethylene glycol), substituted with 2mM ATP and 100mM MgCl2. Proteins 
Ku, XRCC4 and XLF were dissolved in 1X of the above buffer. The total reaction volume was 
10μl, with the protein concentrations of 10nM, 40nM and 100nM of Ku, XRCC4 and XLF 
respectively and 10ng of the labelled substrates. A third of the samples had only DNA and no 
proteins, a third of them had DNA with Ku and XRCC4 while the rest had all the three proteins 
and DNA. The reactions were incubated for 4 hours at 37
o
C. Samples were deproteinized by 
adding an End Joining Lysis buffer containing 0.3 M NaCl, 10Mm EDTA, 20 mM Tris pH 7.6, 
1% SDS and 1mg/ml of Proteinase K for 3 hrs at 56°C. DNA was then extracted with 
phenol/chloroform and precipitated with ethanol for one hour. After the   precipitation, all 
samples were dissolved in 43 μl of TE and digested with 20 units of NdeI and PstI after addition 
of 5 μl of 10X CutSmart buffer (New England Biolabs) at 37°C for 3 hrs. Gel electrophoresis of 
the samples was done in 20% polyacrylamide sequencing gels. Then the gels were exposed to 
phosphor imaging screen for1 to 2 days at -20°C.  Data were analyzed using a Typhoon 9100 
imager (GE Healthcare Bio-Sciences, Pittsburgh) and Image Quant 3.1 or 5.1software (GE 
Healthcare Bio-Sciences, Pittsburgh). 
2.10 Statistics: 
Error bars represent standard error of mean (SEM) for at least three independent experiments. 
Unpaired two-tailed t-tests were performed and the data were reported as significant for P values 
<0.05. 
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 Fig 2.1: Preparation of the substrate: The oligonucleotide with Tg was radiolabeled with P
32
 
at 5′ end is annealed with a complementary strand. This was ligated to the BstAPI cut end of the 
pUC19 using T7 DNA Ligase. The substrate thus prepared had a head with BstAPI and NdeI 
restriction sites and a tail with SmaI and PstI restriction sites. This substrate was used in both cell 
extract ligation assay and assay with recombinant proteins. 
 
 
 
 
 
Method Summary 
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Fig 2.2 :Assay Protocol: Radioactively labeled oligomeric duplexes,containing normal thymine 
or Tg at different positions were ligated with BstAPI digested pUC19. Following attempted 
ligation withT4 DNA ligase or with cell extract containing DNA Ligase IV, or purified proteins, 
plasmids were digested with either NdeI and PstI. Resulting fragment sizes on autoradiograph 
revealed the extent of ligation of the various substrates under the given conditions.  
Inter/intramolecular ligation between the oligomeric duplex end and the end cut with SmaI,   
generated a 44-nucleotide. Intermolecular ligation of two blunt ends of oligomeric duplex, 
generated a 36-nucleotide fragment upon digestion with NdeI in both sides. If there was no 
ligation there will be a 19-nucleotide fragment due to digetion by NdeI. 
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Fig 2.3:  Base excision repair of the substrates: A) When base excision repair proteins 
recognize and remove the Tg from the third position in Tg3, instead of the 19- nucleotide 
fragment 16-nucleotide fragment was formed and there is no end joining. B) When the Tg from 
the Tg5 substrate is removed there was formation of 14- nucleotide fragment and there was no 
end joining. 
 
 
A)
) 
B) 
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                                                                  III RESULTS  
  
 
3.1 T4 DNA ligase assay to test interference with the end joining  by thymine glycol 
  Thymine glycol at the DSB of DNA interferes with the efficiency of end joining, independent 
of the NHEJ process. T4 DNA ligase is a bacteriophage ligase that is capable of ligating 
cohesive or blunt termini of the DNA. Therefore, before testing for NHEJ activity, T4 ligase 
assay was done to determine whether the substrates could be ligated.  Linearized substrate 
plasmids containing 
32
P-labeled oligonucleotide duplexes with normal thymine or Tg at different 
positions from the termini (Tg1, Tg2, Tg3, Tg5) were evaluated for ligation following incubation 
with or without T4 DNA ligase. The ligation products were digested with  NdeI and PstI  in 
order to detect the  fragments that were diagnostic of the efficiency of ligation (Figure 4-1).  The 
unjoined substrate is indicated by a 19-base labeled fragment released by NdeI. For Tg-
containing substrate, this 19-mer forms a doublet due to different stereoisomers of Tg. The 
joined substrate would appear as a 44-base band in the NdeI and PstI digestion of the DNA, if 
the ligation is head-tail in intra or inter molecular ligation. In case of intermolecular ligation 
head-head, digestion with NdeI (with or without PstI) would yield a 36-bp fragment. 
Results of the assay show that T4 Ligase could efficiently ligate the unmodified plasmid head-
tail (61%) and head-head (7%). When the substrates with Tg at different positions were used 
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there was an increasing efficiency of joining with the increasing distance, Tg1 - 1.6%, Tg2-1.9%, 
Tg3-36%, Tg5-44%.The joining was only in Head-Tail (44) in Tg1 and Tg2 and some head-head 
(36Tg) joining was observed  in Tg3 and Tg5 (1.7% and 5.2% respectively). This shows that T4 
Ligase was able to ligate the plasmids with Tg at blunt ends with minimal effeciency in Tg1 and 
Tg2, but as the distance of the Tg from the end increased there was also an increased ligation as 
observed in Tg3 and Tg5. 
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 Fig 3.1: T4 Ligase Assay:  1) Gel displaying ligation of the plasmids Tg0, Tg1, Tg2, Tg3 and 
Tg5 with and without T4 Ligase followed by digestion with NdeI and PstI 2) Graph representing 
the efficiency of ligation of the plasmids in percentage 44-mer indicative of head-tail end 
joining, 36Tg-mer indicative of head-head ligation with Tg in position. 36-mer indicative of 
head-head end joining.                    
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3.2 Ability of NHEJ to ligate the substrate with Tg5 in Bus cell extracts in the presence and 
absence of XLF:  
Previous experiments with Bus cell extracts showed significantly greater end joining with Tg3 
than Tg1 and Tg2. Therefore, ligation of the substrate with Tg at the fifth position Tg5 was 
attempted using XLF deficient Bus cell extract in a time dependent fashion to observe the effect 
of further distancing Tg from the end. The experiment was done with and without XLF addition. 
The end joining was evaluated after digestion with NdeI and PstI enzymes. The control with 
inactive extract shows 36Tg band due small amount of the head-head end joining during 
preparation of the substrate. In the presence of XLF there was an increase in the end joining with 
time both head-tail (44) and head-head (36). There was head-head joining with Tg still present in 
the joined product (36Tg) which can be seen as a shifted band above the 36-base  fragment, 
which has the Tg removed and substituted with thymine. The 36-base strand has palindromic 
bases and hence snaps back on itself to form a hair pin structure. The hair pin bend thus formed 
accelerates the mobility of the 36-base strands.  The shift of 36Tg was because of the 
interference of the Tg with the snap back of the strand on itself. The formation of 36-base strand 
was delayed compared to that of the 44-base strand. With time there was a minimal decrease in 
the joined head- tail (44-base) fragment. In addition to the 19-base fragment which represents 
non-joining, there was a 14-base fragment, presumably as a result of BER. The appearance of 
this 14-base fragment was earlier and greater in magnitude than the end joining (44) fragment. In 
the absence of XLF, there was no detectable end joining head-tail (44-base) but there was 36Tg 
and early appearance of 36-base band. This was likely due to conversion of the 36Tg which was 
formed during preparation of substrate, to 36-base strand by BER and it was partially suppressed 
in the presence of XLF as shown by the delayed appearance. There was an extra band below the 
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36-base band due to joining of the repaired strands with a few nucleotides removed before end 
joining. There was an earlier appearance of the 14-bases strand in the absence than in the 
presence of XLF may be due some inhibition, which needs further evaluation. This data proves 
that presence of XLF is essential for the end joining reaction.  
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  Fig 3.2: The ability of NHEJ to rejoin DSBs with Tg at the fifth position (Tg5): Time 
dependent end joining assays in whole-cell extracts of XLF-deficient Bus fibroblasts with and 
without XLF substitution, with plasmid with Tg at the fifth position from the break. Extracts 
were supplemented with 200nM XLF. 
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3.3 Effect of Endonuclease and ddTTP on the end joining: 
Previously, studies showed that the plasmids containing proximal Tg were joined with Tg still 
present in the joined fragments. To test this in the case of Tg5substrate, Bus Cell Extract assay 
was done in the presence of either ddTTP or dTTP. They are divided in to equal halves, one half  
was treated with Endonuclease III (other half was used as a control), after the end ligation step 
but before digesting with the restriction enzymes. ddTTP functions as a DNA chain terminator 
and hence inhibits the end joining.  Endonuclease III recognizes and removes Tg from the DNA. 
Substitution with ddTTP was found to reduce the intensity of the joined fragments but did not 
inhibit the joining in total. Treatment with Endonuclease III reduced the end joining, as shown 
by the reduced intensity of radioactivity of the head-tail 44-base strand. Treatment with both 
Endonuclease and ddTTP further reduced the intensity of the joined fragment. This experiment 
proves that Tg was not removed from the strand before ligation in at least some end joining 
events. In some cases Tg was removed and replaced with thymine, but the experiment does not 
distinguish whether such replacement occurred before or after end joining. 
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Fig 3.3: The effect of the ddTTP and Endonuclease III on the joined fragment (44):  A) 
Autoradiograph showing the effect of substitution of ddTTP for dTTP during incubation and 
Endonuclease III treatment after the ligation step and before the digestion with NdeI and PstI. B) 
Graph displaying the percentage of 44-base strand on treatment with ddTTP and Endonuclease 
III. 
                                                                                                                                  
A) 
B) 
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3.4 Comparison of End Joining and Base Excision repair between Tg3 and Tg5 in cell 
extracts: 
 To compare the end joining of the plasmids Tg0, Tg3 and Tg5, all three were incubated in either 
heat inactivated cell extracts or Bus cell extracts supplemented with XLF. After treating with 
NdeI and PstI, repair of these substrates showed that Tg0 has 40% total end joining, Tg3 has14% 
and Tg5 has 10%. Thus there was  more end joining in Tg3. In addition to the 19-base fragment, 
there was 16-base fragment in the Tg3 repair lane and a 14-bp fragment in the Tg5 lane. This 
was assumed to be due to the base excision repair of the substrate.  The intensity of the 16-bp 
fragment (48.5%) is greater than 14-bp fragment(7.6%).  Thus, there was much more base 
excision repair with Tg5 compared to Tg3 evident also from the unjoined and unprocessed 
substrate (19-base fragment) was higher in intensity for Tg3 than Tg5 as shown in the Fig 3.5. 
The increased distance of Tg from the end had apparently provided access for the BER repair 
proteins for the excision process and thereby decreased the end joining. Unpaired Two tailed 
tests performed revealed that Tg0 and Tg5 had a statistically significant difference (p<0.0003) 
for the end joining, and Tg3 and Tg5 had p<0.02, thus statistically significant.  
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Fig 3.4: Comparison of the repair between Tg3 and Tg5: A) Autoradiograph showing the 
repair (joining and BER) fragments ofTg0, Tg3 and Tg5 in Bus cell extracts supplemented with 
XLF. B) Graph representing the percentage of both joining and BER fragment for Tg3 and Tg5. 
 
                                                                                                                              
 
 
A) B) 
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3.5 Assessment for fill in and ligation after BER: 
After the BER, the DNA strand repaired was expected to be filled in and ligated. However, even 
after 6 hours of incubation there was no or minimal change in the 14-base fragment. To assess 
the ability of this strand to be filled in, Klenow enzymes which can add nucleotide to the 3′end if 
there is a compatible 3′ OH group and a suitable template strand were used. After the end joining 
reaction in inactivated extracts and 0.25 or 6 hrs in cell extracts substituted with XLF, the 
reaction was treated with either Klenow or Klenow exonuclease
- 
(Klenow fragment which has 
lost its 3′-5′ exonuclease activity). Klenow fragment was able to add the nucleotides to 14 base 
fragment producing bands corresponding to fragments between 14 and 19 bases in length.  For 
the 0.25 hrs sample the entire 14-base band disappears to higher levels but at 6 hrs some of it is 
still present. Klenow exo
- 
added an extra nucleotide to 19-base fragment and nucleotides to 14-
base fragments at 0.25 and 6 hrs.  There was a complete disappearance of the 14-base band at 
0.25hrs whereas at 6hrs not all of it disappears. This persistence of the 14-base fragment and the 
productions of base fragments between 14 – 20 bands at 6 hrs could be probably due to the 
degradation of the complementary stand to various lengths.  There was also a shift in the head-
tail joined fragment to a smaller oligonucleotide level below 44-base band on treatment with 
Klenow fragment and shift of the 36Tg and 36-base band to a higher level. There is no change in 
the 44-base band with Klenow Exo
-
, but a higher shift in 36Tg and 36-base strands was 
observed. This data reveals that there was a 3′-OH group at the 14-base fragment end which was 
not filled in the extracts. The shift observed in 36Tg and 36-base bands might have been due to 
filling of the 5′ overhangs produced by the NdeI digestion on either side of the DNA, by the 5′- 
3′ polymerase activity of Klenow and Klenow Exo-. Shift of the 44-base fragment with the 
Klenow enzyme is difficult to be explained since this band represents an NdeI/PstI fragment 
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generated after Klenow removal and there should have been no free 3′ terminus available for 
modification during treatment with Klenow. 
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Fig 3.5: Testing with the Klenow and Klenow exonuclease
-
 :   Autoradiographs displaying the 
effect of A) Klenow fragment and B) Klenow Exonuclease
-
 on the BER products generated in 
the end joining of the Tg5 plasmids in Bus cell extracts with XLF 
 
                                                                                                                      
 
 
A) B) 
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3.6 Effect of Tg position on total, head-head and head-tail end joining: 
To assess the total extent of ligation, the ligation of Tg0, Tg3 and Tg5 were analyzed on a 0.8% 
agarose gel after the end joining step after proteolysis. This was compared to that of the same 
reactions treated with SmaI after proteolysis. When all the possible end joining of the substrates 
are considered, both Tg3 and Tg5 have similar extent of ligation. When the restriction enzyme 
SmaI was used, there is diminished total end joining in case of Tg5. The similar ligation 
observed for Tg3 and Tg5 was due to joining of the plasmids at the tail ends which are not 
modified and also in Tg5 the tail ends were available for end joining as they was less ligation to 
head. SmaI by cleaving this end joining reduced the intensity leaving the joined fragments only 
in head-tail and head-head. This result confirms the reduced joining of the Tg-containing end of 
Tg5, as compared to Tg3, due to interference with BER.  
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Fig 3.6: Effect of Tg position on total, head-head and head-tail end joining:Autoradiograph 
showing the total end joining of the unmodified (Tg0), Tg3 and Tg5 in the top lane and the result 
of treatment of Sma I in the below lane. 
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3.7 Time dependent end joining and base excision repair of Tg3 and Tg5 plasmid: 
To analyze the kinetics of repair, cell extract ligation assay was performed with Tg3 and Tg5 at 
different time endpoints of 0.25, 0.5, 1, 2, 4, 6, 12 hours of incubation. There was an increased 
head-head and head-tail end joining with time.  From the graph Fig 3.7 B, it is evident that BER 
was more active reaching its peak earlier than the end joining. There was no significant increase 
in the end joining even after the BER had reached the plateau. This inability of the 14-base 
fragment to be filled in and ligated has been already addressed above in the result 3.5 using 
Klenow enzymes. 
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Fig 3.7: Time dependent repair kinetics of Tg3 and Tg5: A) Autoradiograph displaying the 
intensities of the repair fragments as a function of time. B) Graphs displaying the percentage of 
the joined and BER fragments Tg3 in the top and Tg5 below as a function of time. 
                                                                                                                                  
 
 
A) 
B) 
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3.8 Recombinant protein assay: 
After cell extract assays, end joining assays were performed with unmodified, Tg1, Tg2, Tg3, 
and Tg5 using recombinant NHEJ proteins- Ku, X4L4 and /or XLF to observe the effect of these 
core NHEJ proteins on the substrates in the absence of other repair factors. Data showed that the 
unmodified fragment was ligated both in head-tail (44) and head-head (36) with 9% ligation in 
the presence of XLF and 2% in the absence of XLF. Tg1 plasmid showed 0.4% ligation head-tail 
(44) only in the presence of XLF. Tg2 had a slightly higher, 0.6% ligation of the same. Tg3 on 
the other hand has ligation, 0.1% in the absence of the XLF and 2.3% in the presence of XLF. In 
the presence of XLF, there was also a head-head ligation 1% (36Tg), with Tg in place. Tg5 also 
displayed repair in both head - head (0.2%) and head-tail (2%) in the absence of XLF. XLF 
enhanced the ligation of Tg5 to 4% in head-tail fashion and 2% in head-head fashion. Thus 
ligation improved with the increased distance of Tg from the end. But the ligation as a whole was 
3-5 fold less than that observed in extracts, which would suggest the requirement for other repair 
factors for the most efficient ligation. 
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Fig 3.8: Repair by the recombinant NHEJ proteins Ku, X4L4 and/or XLF of Tg0, Tg1, 
Tg2, Tg3 and Tg5: A) Autoradiograph showing the extent of joining of the plasmids by the 
proteins B) Graph displaying the percentage of joining by the proteins in the presence and 
absence of XLF. 
                                                                                                                                  
                                                                                                                            
 
 
B) A) 
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                                                   IV DISCUSSION 
 
                   
              Radiotherapy is a “double edged sword” inducing genetic mutations in the surrounding 
normal tissue while causing a loss of clonogenic survival of tumor cells 
(267)
. IR has the 
propensity to induce more than a single lesion in the DNA in one or two helical turns, known as 
“clustered damage” including the modified bases, SSBs and DSBs.  These clustered lesion show 
reduced reparability when compared with that of individual lesions 
(268)
. And when these lesions 
are in combination with DSB they were the poor substrates for repair
 (43, 72)
 
Thymine glycol being the most common modified/oxidized base formed during radiotherapy, 
(76)
   
is repaired mainly by Base Excision Repair Pathway 
(76)
. NHEJ repair pathway proteins, 
comprising DNA-PK, XLF, the X4L4 complex, and polymerases belonging to PolX family, have 
the ability to ligate the termini of DNA breaks that do not require extensive processing, with high 
efficiency. However, many DSB are associated with complex lesions that can be barriers to the 
end joining 
(266)
.  The current study involves the evaluation of effect of the presence of thymine 
glycol on the NHEJ repair pathway in cell extracts and by recombinant proteins. 
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   T4 ligase, the bacteriophage ligase has been shown to efficiently ligate the blunt, compatible, 
non-compatible 
(269)
 and branched DNA ends 
(271)
. Ligation assay with T4 Ligase was done to 
assess its ability to ligate modified DNA ends as compared to X4L4 which presumably evolved 
specifically to ligate the modified substrates. Assays revealed that T4 Ligase can ligate the 
unmodified ends efficiently. The modified substrates joining efficiency increase with the 
increasing distance of the modified base from the end.  This joining was head-tail (44) both in 
inter and intra molecular fashion, where only one end is modified, with increasing ligation as the 
Tg is moved to increasing distance from the end.  In contrast, presence of the Tg at both the 
completely blocked head-head joining (36Tg bp) in Tg1 and Tg2, but allowed some joining in 
Tg3 and Tg5 with the thymine glycol in place (36Tg). As there were no other processes to 
remove Tg from the strand, the strands are ligated with Tg in place. The 36Tg band is higher 
than the 36-base band as there was a palindromic sequence in the strand which formed a hair pin 
bend in 36-base oligonucleotide. Tg interfered with the formation of this hair pin structure in 
36Tg, retarding the mobility. Thus, presence of Tg near the end of the DSB distorted the ends 
such that T4 Ligase could not ligate the end but when moved just a few bases away from the end 
there was ligation. 
 Previous studies in our laboratory with the Bus cell extracts using substrates Tg1, Tg2 and Tg3 
revealed that the ends with Tg at the first and the second position of the DSB are less joined 
head-tail and not joined head-head. But Tg3 showed repair almost equal to unmodified ends both 
head-tail and some joining head-head. In the current study substrate with Tg at the fifth position 
(Tg5) is used to observe the trend of the repair with the increased distance from the end in the 
cell extracts. Bus cell extracts which are XLF deficient were used to detect the ligation of the 
substrates. Ligation is assessed in the extracts in the presence and absence of XLF in a time 
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dependent fashion. Two main observations were made in this process.  There was an increase in 
both head-tail and head-head with XLF substitution. But there was base excision repair in both 
the presence and absence of the XLF.  But the BER appears to be inhibited initially in the 
presence of XLF as evident from the Fig 3.2, there was less and delayed BER in the reaction 
with XLF. There was a 36Tg oligonucleotide strand formed during the preparation of the 
substrate due to the some ligation of the blunt ends in head-head fashion. This 36Tg stand could 
be observed in the control treated with inactive extract. In the absence of XLF this 36Tg strand 
was converted to 36-base strand early by the BER and not in its presence. This might be because 
the presence of XLF had inhibitory effect on BER. This effect of XLF on BER should be 
evaluated further.There was also some ligation of the BER repaired strand and it appears below 
the 36 base band because of loss of some nucleotides. Base excision repair appeared to be 
activated almost immediately in the first quarter of the hour, repairing the end forming the 14-
base oligonucleotide with the removal of Tg at the fifth position in the 19-base unjoined strand. 
Though there was a halt in the BER as shown by the intensity of the 14-base strand, there was no 
significant increase in the end joining of the plasmid. 
  
       The plasmids Tg1, Tg2 and Tg3 were shown to be ligated with Tg still in position. The same 
was tested with Tg at 5
th
 position. Addition of ddTTP which blocks the extension of the strand 
by polymerases and ligation of the strands, instead of dTTP while incubation had reduced but did 
not eliminate the intensity of the radioactivity suggesting that Tg had not been totally removed 
from all strands and at least in some instances they were ligated with the Tg in position, proving 
that Tg in the fifth position is not a hindrance for the end joining. Treatment with Endonuclease 
III after the ligation step removed Tg from the ligated strand and reduced the radioactivity of the 
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joined fragment, which is also consistent with the above result.  There was further decrease in the 
intensity of the joined fragment with ddTTP and Endonuclease III due to the presence of some 
normal thymidine in the extract. 
    Modified bases placed at different positions from the break displayed different repair 
characteristic depending on the type of the lesion. As discussed in the study of the effect of the 
glycosylases, NTHI, OGGI and NEILI on lesions 5-hydroxyuracil (5-OHU) and 8-oxoguanine 
(8-oxoG), the repair is variable depending on the type and position of the lesion 
[272]
. Previous 
studies in the lab revealed that there was no detectable BER prior to end joining for Tg1 or Tg2, 
some was observed in Tg3. To evaluate the effect of increasing the distance of Tg from the DSB 
on the repair of the modified substrates in Bus cell extracts, Tg5 repair was studied in 
comparison with the Tg3 substrates.  This experiment revealed that there was a reduced end 
joining for Tg5. In addition, there was much more extensive activation of the Base excision 
repair pathway for Tg5 than that observed for Tg3. This observation denotes that the positioning 
of the Tg at the ends in DSB can result in poor binding and low activity for the BER proteins and 
increased distance from the end provides a better substrate for the activity of BER. When the 
time-dependent kinetics for both Tg3 and Tg5 were studied, BER pathway was activated almost 
immediately compared to the end joining repair. While the BER reached the plateau at 1 hour 
time point, the end joining did not show a significant increase. This observation led to question 
of the end processing of the substrate by BER proteins as APE1 should leave a compatible 3′-OH 
group and either polλ/polμ (NHEJ) or pol β (BER) should have filled in the gap for end joining.  
There was less increase in the end joining than expected of it with time even in the presence of a 
robust BER. In order to test for the compatibility of the repaired 3′ end for the addition of 
nucleotides Klenow enzymes (Klenow fragment and Klenow Exonuclease-) were used. Klenow 
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enzyme was able to add nucleotides to the 14-bases strand resulted from BER, producing 
multiple bands between 14 -19- bases. At 0.25 hrs there was complete disappearance of the 14-
bases strand to the higher levels while some of it was still in place at 6hrs. Though there should 
be a conversion of the whole 14-base strand to 19-bases at 0.25 hrs due to the polymerase 
activity of the Klenow fragment, its exonuclease activity dominated producing bands of various 
length. At 6hrs, the bands from 14 to 19-base strand indicate that the complementary strand has 
been digested over time. This addition of the nucleotides suggests that the 3′ end of the 14-base 
strand has OH group and can be filled in. When Klenow exonuclease- enzyme was used, in 
addition to filling the nucleotides from 14-base -19-base, it added an extra nucleotide to the 19- 
base strand. This was because of lack of the exonuclease activity which allowed the polymerase 
activity to add nucleotides to the 14- base strand and convert it completely in to 19-base or 20-
base strand  at 0.25 hrs, as the complementary strand is completely intact. As the complementary 
strand was digested to variable lengths in cell extracts by 6 hrs of incubation, multiple bands 
were formed due to the polymerase function.  An extra nucleotide was added to the 19-base 
strand as there was no exonuclease activity 
[270]
. This result indicated that the BER product had a 
compatible 3′ OH for the polymerases in the cell extracts to fill in. The reason why extracts could 
not do it,  needs to be evaluated further. The shift in the 36Tg and 36-bases fragment with both 
the enzymes might have been due to the filling of the ends with 5 'overhangs created by the NdeI 
digestion in 3′-5′ direction by the polymerase activity of the Klenow and Klenow Exo- enzyme.     
      When the total end joining efficiency of the Tg5 was compared with that of Tg3 in the 
extract using agarose gels, there was an equal amount of total end joining in Tg3 and Tg5. This 
was due to the tail- tail ligations, which do not have Tg and hence ligated efficiently. And also as 
the end-joining head-tail was less with Tg5, there was more availability of tails for the joining. 
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SmaI had reduced the intensity of the joined fragments in Tg5 by cleaving these tail-tail 
ligations, leaving the head-head and head-tail ligations intact. Thus joining of the Tg-containing 
end was less for Tg5 than Tg3, due to interference by BER in Tg5. 
    End joining assays in the previous studies with the recombinant proteins have shown that 
compatible ends can be repaired efficiently even in the absence of the XLF protein and there was 
moderate and strong stimulation of the ligation of the blunt and incompatible ends respectively 
by XLF
(269)
.  Based on this, repair of the blunt ends with the Tg was attempted using core NHEJ 
recombinant proteins Ku, X4/L4 and XLF. Tg1 and Tg2 required the presence of XLF for 
ligation, while Tg3 and Tg5 displayed some ligation even in the absence of the XLF. The extent 
of ligation of Tg3 and Tg5 was boosted 5-6 fold when XLF is added. Presence of the Tg at the 
ends might have resulted in their distortion making it impossible for the Ku and X4L4 to join 
these ends. XLF along with XRCC4 forms a filament across the DNA ends perhaps stabilizing 
the alignment of distorted ends. In addition, XLF might have helped to overcome the limitation 
by stimulating the LigaseIV activity due to its re-adenylation function 
[210-213]
, allowing the end 
joining. Previous studies in the lab showed that XLF was an absolute requirement in extracts for 
the end joining reaction by NHEJ irrespective of the position of the Tg. In contrast, there is some 
ligation in the absence of XLF in Tg3 and Tg5 in the study of recombinant proteins. This could 
be due to competition between some other repair proteins and X4L4 in extracts for the DSB or 
failure of the more distorted ends to stimulate the ligase activity of X4L4. Under these 
conditions, XLF was required to promote the ligation. These ligated products had Tg, as there 
was no processing of proximal Tg residues in the ends due to lack of the BER proteins required 
for the same. The extent of joining with the purified proteins was 3-5 fold less than the joining in 
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the extracts suggesting that other structural and enzymatic proteins are required to efficiently 
stimulate the end joining in extracts. 
 In future, the effect of other proteins of NHEJ such as DNAPKcs, PAXX is to be tested to 
analyze the effect of these proteins on the end joining. BER proteins, NTH1 and NEILI 
with/without APEI can be added to the NHEJ proteins to study the effect on the modified 
plasmids. These modified plasmids can be transfected in to cells to study the repair by other 
repair proteins and pathways which may not have survived the extraction process. Repair of 
these substrates can be evaluated after the DNA isolation and RT-PCR with the primers on either 
side of the DNA modification and also analyzed by high-throughput DNA sequencing.  
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                         V.CONCLUSION                                                                                                                  
 
   The position of the modified base (Tg) alters the end joining of the blunt ends. Tg also affected 
the activity of the base excision repair.  In the cell extracts the Base excision repair pathway was 
more active and competes with the End joining reaction especially if the base was far from the 
end shown by the more joining for Tg3 and more Base excision repair for the Tg5. XLF was 
mandatory for the repair of the plasmids in extracts. Recombinant proteins more efficiently 
repaired the plasmids when Tg was located further away from the DSB, suggesting possible less 
distortion of the ends. The absolute requirement for XLF in the repair of plasmids with Tg near 
the end reiterates its role in stimulating X4L4 at the incompatible ends. XLF is  required by 
X4L4 enzyme to overcome the competition with other proteins in the extract at the DSB. 
Decreased repair by purified proteins denotes the requirement of other proteins and repair 
mechanisms for the effective repair of these complex lesions. 
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